Skip to main content

Table 4 Model 1 for the multivariate Cox regression analysis for RFS

From: The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma

 

peakSUVmax

HR (95%CI)

p-value

hSULpeak

HR (95%CI)

p-value

TMTV

HR (95%CI)

p-value

wTLG

HR (95%CI)

p-value

cT stage, T1–2 / T3

1.980 (1.126–3.480)

0.018

1.995 (1.137–3.499)

0.016

1.733 (0.987–3.043)

0.056

2.081 (1.167–3.771)

0.013

cN stage, N0 / N1–2

0.522 (0.297–0.914)

0.023

0.515 (0.295–0.900)

0.020

0.544 (0.316–0.939)

0.029

0.498 (0.277–0.897)

0.020

cM stage, M0 / M1(LYM)

 peakSUVmax, < 4.43 / ≥4.43

1.907 (0.984–3.699)

0.056

      

 hSULpeak, < 2.64 / ≥2.64

  

1.916 (0.987–3.719)

0.055

    

 TMTV, < 3.82 / ≥3.82

    

2.574 (1.338–4.826)

0.004

  

 wTLG, < 13.46 / ≥13.46

      

1.560 (0.802–3.037)

0.19

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us